For everyone who might think CHM is rooted ...and clearly there...

For everyone who might think CHM is rooted ...and clearly there are a lot of people who do .

1. @Krushinlt posted regarding the presentation yesterday & thanks for doing so - see text below .

"I attended today's briefing in Sydney:

• Well attended and generally upbeat;
• Rebecca was articulate and hit the right notes with her presentation;
• Wouldnt be surprised if she steps into the CEO role at some future date;
• All 4 clinical trials are progressing well;
• Interim data read outs are expected in Q3 and Q4. (Earlier than expected!);
• She confirmed my view that CDH17 is the jewel in the crown - biggest addressable market and leading tech in-licensed from the pioneers of CART therapies;
• FDA interactions have been positive - Orphan Drug Status will be a no brainer for some of the therapies. Similarly, Fast Track Designation definitely on the cards;
• Paul Hopper did not attend as he was OS on other business (disappointing but I knew he was not in AU);"

2. There are quite a few players in the CarT Field ...... & given the minute market cap of CHM at current prices ..... if there is a "sniff of interest " in what CHM are are doing ..... a valuation on the IP could come in at 10 - 20 times the current market cap of CHM .


3. People who subscribed to the float @ 30 cents ( assuming there are some left ) could do a lot worse than to pick up more stock at 1 / 13th of the price they paid for it X 3 - 4 Years ago .

4. A lot of believers picked up stock @ 7- 8 cents ...and lower - clearly the stock is right out of favour

5. I'm expecting a tirade of moaning form Steini about Paul Hopper etc etc etc ---- ignore that broken record - its been done to death ! ( no offence man ) - think about the IP and the current progress and where this could go

Thats my thought for the day ...... and lets see what evolves down the track

LOL